This page includes the latest FDA filings for Cordis Us Corporation14201 Nw 60th Avenuemiami Lakes Fl 33014 Pma Numberp120002 Supplement Numbers020 Date Received09 01 2021 Decision Date02 25 2022 Product Code Nip Advisory Committee Cardiovascular Clinical Trialsnct00739102 Supplement Typenormal 180 Day Track Supplement Reason Change Design Components Specifications Material Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Cordis US Corporation14201 Nw 60th Avenuemiami Lakes, FL 33014 PMA NumberP120002 Supplement NumberS020 Date Received09/01/2021 Decision Date02/25/2022 Product Code NIP Advisory Committee Cardiovascular Clinical TrialsNCT00739102 Supplement Typenormal 180 Day Track Supplement Reason Change Design/components/specifications/material Expedited Review Granted? No | S.M.A.R.T. RADIANZ Vascular Stent System | 2022-02-25 |